Global Proton Therapy Market 2018-2022
|発行||TechNavio (Infiniti Research Ltd.)||商品コード||316436|
|出版日||ページ情報||英文 116 Pages
The incidence of many cancers such as lung cancer, breast cancer, prostate cancer, colorectal cancer, and stomach cancer is increasing globally. The associated risk factors of cancers are also on the rise. A significant proportion of the risk of cancer incidence is attributed to the high body mass index, poor dietary habits lack of physical activity, tobacco use and alcohol consumption. Technavio's analysts have predicted that the proton therapy market will register a CAGR of over 9% by 2022.
Protons can be charged to reach the exact depth where a tumor is located, then stop its further growth. Therefore, proton beams minimize exposure to the nearby healthy tissue surrounding the tumor.
The high capital costs of proton therapy facilities are restricting their adoption worldwide.
For the detailed list of factors that will drive and challenge the growth of the proton therapy market during the 2018-2022, view our report.
The global proton therapy market is highly concentrated and the market being in a growth phase, the competition among companies is intense. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.